HomeGERN • NASDAQ
add
Geron Corp
Nakaraang pagsara
$3.01
Sakop ng araw
$2.92 - $3.09
Sakop ng taon
$1.64 - $5.34
Market cap
1.78B USD
Average na Volume
12.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 28.27M | 17,138.41% |
Gastos sa pagpapatakbo | 35.88M | 95.51% |
Net na kita | -26.45M | 40.97% |
Net profit margin | -93.55 | 99.66% |
Kita sa bawat share | -0.04 | 50.00% |
EBITDA | -28.18M | 40.67% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 339.77M | 8.37% |
Kabuuang asset | 444.95M | 7.73% |
Kabuuang sagutin | 152.67M | 24.72% |
Kabuuang equity | 292.28M | — |
Natitirang share | 604.50M | — |
Presyo para makapag-book | 6.27 | — |
Return on assets | -15.77% | — |
Return on capital | -18.24% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -26.45M | 40.97% |
Cash mula sa mga operasyon | -58.94M | -15.94% |
Cash mula sa pag-invest | -554.00K | 88.25% |
Cash mula sa financing | 3.58M | -87.81% |
Net change in cash | -55.87M | -113.30% |
Malayang cash flow | -50.01M | -48.27% |
Tungkol
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Itinatag
1990
Headquarters
Website
Mga Empleyado
141
